Cabaletta, Cellares Sign Manufacturing Deal for Rese-Cel Supply
PHILADELPHIA, PA & SOUTH SAN FRANCISCO, CA — Cabaletta Bio, Inc. (Nasdaq: CABA) and Cellares have entered a commercial agreement to manufacture rese-cel, an investigational cell therapy for autoimmune diseases, …
Cabaletta, Cellares Sign Manufacturing Deal for Rese-Cel Supply Read More